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ABSTRACT
ÖZ
Amaç: Yeni antibakteriyel ilaç geliştirilme çalışmalarında indol ve türevleri önemli bir bileşik sınıfı oluşturmaktadır. Ayrıca azoller ve türevlerinin 
antibakteriyel ve antifungal gibi biyolojik aktivite gösterdikleri dikkat çekmektedir. Bu çalışmada 1,2,4-triazol, 1,3,4-tiyadiazol ve hidrazinkarbotiyoamid 
ile sübstitüe edilmiş indol türevi yeni bileşiklerin, antimikrobiyal etkinlikleri araştırılarak değerlendirilmiştir.
Gereç ve Yöntemler: Yeni bileşiklerin antimikrobiyal etkinlikleri, 2-kat seri dilüsyon yöntemi kullanılarak, Staphylococcus aureus, MRSA, Escherichia 
coli, Bacillus subtilis, Candida albicans ve Candida krusei’ye karşı araştırılarak değerlendirilmiştir.
Bulgular: Yeni sentezlenen bileşiklerin MİK, sultamisilin, ampisilin, flukonazol ve siprofloksasin gibi standart referans bileşiklere karşı belirlenmiştir.
Sonuç: Bileşikler test edilen mikroorganizmalara karşı 3.125-50 µg/mL gibi geniş spektrum aralığında MİK değerleri göstermişlerdir. Bu çalışmada 
değerli veriler elde edilmiş ve indol-triazol türevi olan 3d bileşiği antibakteriyel ve antifungal lider bileşik olarak ileri çalışmalar için gelecek vaad 
etmektedir.
Anahtar kelimeler: İndol, 1, 2, 4-triazol, 1, 3, 4-tiyadiazol, MRSA, C. krusei
Objectives: In new antimicrobial drug development studies, indole and its derivatives create an important class of compounds. In addition, azoles 
and their derivatives were recognized to be associated with a variety of biologic activities such as antibacterial and antifungal. In this study 
antimicrobial activities of some indole derivatives mainly substituted with 1,2,4-triazole, 1,3,4-thiadiazole and hydrazinecarbothioamide were 
investigated to evaluate their efficacy.
Materials and Methods: The efficacy of new compounds was evaluated using 2-fold serial dilutions against Staphylococcus aureus, MRSA, Escherichia 
coli, Bacillus subtilis, Candida albicans, and Candida krusei.
Results: The MIC was determined for test compounds and for the reference standards sultamicillin, ampicillin, fluconazole, and ciprofloxacin. 
Conclusion: The compounds possessed a broad spectrum of activity having MIC values of 3.125-50 µg/mL against the tested microorganisms. This 
study provides valuable evidence that the indole-triazole derivative compound 3d holds significant promise as a novel antibacterial and antifungal 
lead compound. 
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INTRODUCTION
Antimicrobial resistance is often used as a definition for drug 
resistance, which occurs when microorganisms such as 
bacteria, viruses, fungi, and parasites withstand a drug that was 
intended to cure the infection.1,2 Multidrug-resistant strains of 
Methicillin-resistant Staphylococcus aureus (MRSA) cause some 
serious infections such as pneumonia, endocarditis, and skin 
and soft tissue infections within intensive care units.3,4 Recent 
studies confirmed that indole derivatives have promising 
antimicrobial activity against various microorganisms including 
MRSA.5 Studies showed that one of the main contributors to 
Staphylococcus aureus antibiotic resistance is the NorA efflux 
pump.6,7 NorA is able to export a variety of structurally unrelated 
drugs, such as fluoroquinolones, ethidium bromide, cetrimide, 
benzalkonium chloride, tetraphenylphosphonium bromide, 
and acriflavine.8 Indoles are one of the reported classes of 
NorA inhibitors,9 for example, 5-nitro-2-phenylindole, which 
characterizes a promising lead structure able to produce a 
4-fold increase in S. aureus susceptibility to ciprofloxacin.10 Tert-
butyl (2-(3-hydroxyureido)-2-(1H-indol-3-yl)ethyl) carbamate, 
which is not toxic to human cells, was also found to be an active 
indolic NorA inhibitor.11
Azole-containing compounds such as fluconazole, ketoconazole, 
and itraconazole are the most widely used antifungal agents in the 
clinic.12,13 Despite all the claims, many studies have demonstrated 
the ineffectiveness of fluconazole against Candida krusei,14,15 
which has been recognized as a potentially multidrug-resistant 
fungal pathogen.16 Consequently, it is essential to develop new 
active compounds against fungal pathogens including C. krusei. 
Multidrug-resistant infection strains are diseases of emerging 
healthcare concern and have demanded the attention of 
researchers. Synthesis and antifungal activity of indole-linked 
triazole derivatives17 showed that almost all indole derivatives 
showed excellent antifungal activities against Candida albicans 
and C. krusei with low minimum inhibitory concentration (MIC) 
values.18 Antimicrobial activity studies of some 1,2,4-triazole 
and 1,3,4-thiadiazole derivatives indicated good antimicrobial 
activity.19,20 In addition, it is well known that imidazoles and 
triazoles (azoles) make up the largest group of agents against 
mycosis infections.21 Indole derivatives were found to be 
particularly effective and suitable for further developments in 
antimicrobial drug development studies.22
This study is part of an ongoing project in the search for novel 
antimicrobial drug candidates, especially against MRSA and 
C. krusei. New indole derivatives substituted with triazole, 
thiadiazole, and carbothioamide were tested against S. aureus, 
MRSA, Escherichia coli, Bacillus subtilis, C. albicans and C. 
krusei using the 2-fold serial dilution technique. The MIC was 
determined for the test compounds and for the reference 
standards sultamicillin, ampicillin, fluconazole, and ciprofloxacin.
MATERIALS AND METHODS
Chemistry
The synthesis and spectroscopic characterization of 31 indole 
derivatives (Table 1) were published in our earlier study.23 The 
reaction of indole 3-acetylhydrazine with isothiocyanates in ethanol 
under reflux gave the corresponding hydrazinecarbothioamides 
(1a-h). Treatment of 1a-h under acidic conditions with full region 
chemical control gives the corresponding 2-aminothiadiazoles 
(2a-h). Conversely, treatment of 1a-h under basic conditions (aq. 
NaOH) with heating produced 3-thiotriazoles (3a-h). Triazoles 
(3a-h) could be further alkylated under basic conditions to yield 
substituted triazoles (4a-g).
Microbiology
Antibacterial and antifungal activity tests were conducted against 
standard strains. The American Type Culture Collection (ATCC) 
strains of the microorganisms used in this study were obtained 
from the culture collection of the Refik Saydam Health Institution 
of Health Ministry, Ankara, and maintained at the Microbiology 
Department of the Faculty of Pharmacy of Ankara University. 
Mueller-Hinton broth (MHB) (Difco), Mueller-Hinton agar (MHA) 
(Oxoid), Sabouraud Dextrose agar (SDA) (Difco), and Sabouraud 
Dextrose broth (SDB) (Difco), were used for growing and diluting 
the microorganism suspensions. The following reference strains 
were used for testing antimicrobial activity: Gram-positive 
bacteria: S. aureus ATCC 25923, MRSA ATCC 43300, B. subtilis 
ATCC 6633. Gram-negative bacteria: E. coli ATCC 25922, Yeast: 
C. albicans ATCC 10231 and C. krusei ATCC 6258.
Antibacterial and antifungal activity assay
The bacterial strains were maintained on MHA medium for 24 
h at 37°C and fungi were maintained on SDA for 48 h at 25°C. 
Overnight cultures were prepared by inoculating approximately 
2 mL MHB with 2-3 colonies of each organism taken from 
MHA. Inocula were prepared by diluting overnight cultures 
into 0.9% sterile saline solution until the visible turbidity was 
equal to 0.5 Mcfarland standard having approximately 108 CFU/
mL for bacteria and 107 CFU/mL for yeasts. The tube dilution 
technique was used for the determination of the MICs.24,25 
Indole derivatives were investigated to evaluate their efficacy 
against multi-drug-resistant microbial infections by using the 
2-fold serial dilution technique against S. aureus, MRSA, E. coli, 
B. subtilis, C. albicans and C. krusei.
The synthesized compounds and standards were dissolved in 
12.5% DMSO at concentrations of 200 µg/mL. Further dilutions 
of the compounds and standard drugs in the test medium were 
prepared at the following quantities of 400, 200, 100, 50, 25, 
12.5, 6.25, 3.12, 1.56 and 0.78 µg/mL concentrations with MHB 
and SDB. A set of tubes containing only inoculated broth was 
used as controls. 
After incubation for 24 h at 37°C for the antibacterial assay 
and for 48 h at 25°C for the antifungal assay, the last tube 
with no growth of microorganism and/or yeast was recorded 
to represent the MIC (expressed in µg/mL). The MIC was 
determined for test compounds and for the reference standards 
sultamicillin, ampicillin, fluconazole, and ciprofloxacin. Every 
experiment in the antibacterial and antifungal assays was 
performed in duplicate.
There was no need for ethics committee approval because the 
study was conducted in vitro.
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RESULTS AND DISCUSSION
Antimicrobial activity was investigated by finding the MICs of 
the indole derivatives against S. aureus, MRSA, E. coli, B. subtilis, 
C. albicans and C. krusei strains and comparing with ampicillin, 
sultamicillin, ciproflaxacin and fluconazole as standard drugs. 
The MIC values of the compounds and standard drugs are 
given in Table 2. The MIC values were within the range of 
3.125-50 µg/mL. Most of the compounds showed significant 
antibacterial activity against S. aureus, MRSA, E. coli, and B. 
subtilis. In addition, the compounds demonstrated a good level 
of antifungal activity, particularly against C. krusei, even more 
effective than the standard drug fluconazole. 
The antibacterial activity of all tested compounds demonstrated 
acceptable antibacterial effects. Compounds 1c, 1h, 3h, and 
4c showed moderate activity against S. aureus compared 
with ampicillin, sultamicillin, ciprofloxacin; the most effective 
compounds were 2h (indole-thiadiazole) and 3d (indole-
triazole) with an MIC value of 6.25 µg/mL (Figure 1a).
Figure 1b shows the antibacterial effects of the tested 
compounds against MRSA strains. The activities of compounds 
SHIRINZADEH et al. 1,2,4-Triazole, 1,3,4-Thiadiazole and Carbothioamide
MLT: Melatonin
Table 1. Chemical structures of new indole-based MLT analogues
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1d, 1h, 2b, 2h, and 3h were found to be at the same level as 
ciprofloxacin, and compounds 2c (indole-thiadiazole) and 3d 
(indole-triazole) demonstrated excellent activity against MRSA, 
being more effective than ciprofloxacin. The other tested 
compounds were found to have the same activity value or were 
more active than ampicillin and sultamicillin.
None of the tested indole derivatives were more active than 
ciprofloxacin, which has an MIC value of 0.09 µg/mL against E. 
coli. However, most of the synthesized compounds demonstrated 
the same or lower MIC values compared with ampicillin and 
sultamicillin (Figure 2a). Finally, the effects of the tested indole 
derivatives against B. subtilis strains (Figure 2b) showed that 
the most effective compounds were 2c (indole-thiadiazole) and 
3c (indole-triazole) with an MIC value of 3.125 µg/mL. Although 
the tested compounds were not as active as ciprofloxacin and 
sultamicillin, they were much more active than ampicillin.
The MIC values of the tested indole derivatives indicated that 
nearly all them showed excellent antifungal activities against 
C. krusei and moderate activities against C. albicans compared 
with the standard drug fluconazole. Figure 3a shows the MIC 
values of the indole compounds against C. albicans compared 
with fluconazole. The most effective compounds were 1b, 2b-d, 
and 3b-d, with MIC values of 3.125 µg/mL. Although the activity 
results against C. albicans were not very satisfactory, the 
results of antifungal activity against C. krusei strains were quite 
promising. All the tested compounds were found several times 
more effective than fluconazole. As seen in Figure 3b, most of 
the effective compounds 1a, 1b, 1d/2a-d/3a-d, 3h, and 4a, 4d-g 
Table 2. MIC values (µg/mL) of tested indole derivatives
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1a 25 25 25 50 6.25 3.125 2a 25 25 25 25 6.25 3.125
1b 25 12.5 25 25 3.125 3.125 2b 25 6.25 25 25 3.125 3.125
1c 12.5 25 25 25 12.5 6.25 2c 25 3.125 25 3.125 3.125 3.125
1d 25 6.25 25 25 6.25 3.125 2d 25 25 25 25 3.125 3.125
1e 50 50 25 25 6.25 6.25 2e 50 50 25 25 6.25 6.25
1f 50 12.5 25 50 25 12.5 2f 25 25 25 25 12.5 12.5
1g 25 25 25 25 12.5 12.5 2g 50 25 25 25 12.5 12.5
1h 12.5 6.25 25 25 12.5 6.25 2h 6.25 6.25 50 6.25 12.5 6.25
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3a 50 25 25 25 12.5 3.125 4a 25 25 25 12.5 12.5 3.125
3b 25 12.5 25 25 3.125 3.125 4b 50 50 25 50 12.5 6.25
3c 25 50 25 3.125 3.125 3.125 4c 12.5 25 25 25 12.5 6.25
3d 6.25 3.125 50 25 3.125 3.125 4d 50 50 25 50 12.5 3.125
3e 50 25 25 25 6.25 3.125 4e 50 50 25 50 6.25 3.125
3f 25 25 25 25 12.5 12.5 4f 50 50 25 50 12.5 3.125
3g 25 12.5 25 50 6.25 3.125 4g 25 25 25 25 12.5 3.125
3h 12.5 6.25 25 12.5 6.25 3.125 - - - - - - -
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Sultamicillin 0.39 25 25 0.78 - -
Ampicillin 0.78 50 50 50 - -
Fluconazole - - - - 1.56 64
Ciprofloxacin 0.78 6.25 0.19 0.09 - -
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had MIC values of 3.125 µg/mL, whereas fluconazole has an MIC 
value of 64 µg/mL. The results were in accordance with those 
found by Na, 2010.17 The most potent antifungal activity against 
C. krusei was obtained with halogenated indole derivatives.
CONCLUSIONS
According to the activity results, all of synthesized compounds 
demonstrated significant antibacterial and antifungal effects, 
and the antifungal effects of compounds 3a-h are promising for 
development into new, more effective lead compounds against 
C. krusei. Roughly 17% of Candida isolates exhibit resistance 
against azoles, and most probably, the extensive use of 
fluconazole is the main reason for this resistance. C. krusei is one 
of the species that shows actual resistance to fluconazole.16,26 
Therefore, the search for new and more effective anti-fungal 
agents against C. krusei seems ever more important.27 Azole 
compounds prevent the synthesis of ergosterol by inhibiting 
the cytochrome P-450-dependent enzyme lanosterol 
14α-demethylase. Triazoles have a broad range of applications 
in the treatment of fungal infections because of their good 
affinity for fungal cytochrome P-450 enzymes.28 It is reasonable 
to assume that the synthesized indole-triazole derivatives (3a-
h, 4a-g) have the same mechanism of action.
Compounds 2c (indole-thiadiazole) and 3d (indole-triazole) 
demonstrated excellent activity against MRSA at a much higher 
level than ciprofloxacin. It was observed that compounds 1h, 2h 
and 3h had MIC values of 6.25 µg/mL, which is the same as for 
ciprofloxacin. All these compounds have a m-chlorophenyl group 
as a substituent. This shows that both the indole ring and the 
side chains are important for activity. Singh stated that chloro 
substituents for triazolylindole derivatives were beneficial as 
well as hydroxy and methoxy substitution for activity.29
Most of the tested indole derivatives were found to be highly 
active against C. krusei. Between the tested indoles, the most 
active compounds were found in the indole-triazole group, 
followed by the indole-thiadiazole group. These results suggest 
that the tested indole derivatives are eligible for development 
as candidates, especially compound 3d, which is a promising 
lead compound mainly against MRSA and C. krusei. However, 
further research needs to be performed to determine the 
specific mode of action and approve indole derivatives as 
antimicrobial agents.
The common use of antifungal molecules combined with 
insufficient treatment are responsible for promoting these 
microorganisms’ resistance to drugs used in treatment. The 
antibacterial and antifungal activity results were thought to 
Figure 1. a) The MIC value of synthesized compounds against S. aureus 
compared with ampicillin, sultamicillin, ciprofloxacin. b) The MIC value 
of synthesized compounds against MRSA compared with ampicillin, 
sultamicillin, and ciprofloxacin
Figure 2. a) The MIC value of synthesized compounds against E. coli 
compared with ampicillin, sultamicillin, ciprofloxacin. b) The MIC value 
of synthesized compounds against B. subtilis compared with ampicillin, 
sultamicillin, ciprofloxacin
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be exerted through a target because the introduction of the 
substituent groups on the indole caused differences in the 
activity. Therefore, modifications of these compounds should 
continue to be investigated.
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